Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
10.43
-0.07 (-0.67%)
Nov 20, 2024, 4:00 PM EST - Market closed
Eton Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Revenue | 34.68 | 31.64 | 21.25 | 21.83 | 0.04 | 0.96 | Upgrade
|
| Revenue Growth (YoY) | 5.64% | 48.90% | -2.66% | 55879.49% | -95.93% | - | Upgrade
|
| Cost of Revenue | 14.11 | 10.58 | 6.93 | 2.83 | 0.44 | 0.45 | Upgrade
|
| Gross Profit | 20.57 | 21.06 | 14.32 | 19.01 | -0.4 | 0.51 | Upgrade
|
| Selling, General & Admin | 20.61 | 18.93 | 18.58 | 14.27 | 12.67 | 7.61 | Upgrade
|
| Research & Development | 5.17 | 3.32 | 4 | 6.23 | 14.05 | 11.5 | Upgrade
|
| Operating Expenses | 25.78 | 22.25 | 22.58 | 20.5 | 26.71 | 19.11 | Upgrade
|
| Operating Income | -5.22 | -1.19 | -8.26 | -1.5 | -27.11 | -18.6 | Upgrade
|
| Interest Expense | -0.85 | -1.06 | -0.96 | -1.04 | -0.88 | -0.1 | Upgrade
|
| Interest & Investment Income | 1.56 | 1.56 | 0.19 | 0.04 | 0.03 | 0.38 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.8 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -5.31 | -0.69 | -9.02 | -2.5 | -27.97 | -18.32 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.18 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.37 | - | - | Upgrade
|
| Pretax Income | -5.31 | -0.69 | -9.02 | -1.96 | -27.97 | -18.32 | Upgrade
|
| Income Tax Expense | 0.18 | 0.25 | - | - | - | - | Upgrade
|
| Net Income | -5.48 | -0.94 | -9.02 | -1.96 | -27.97 | -18.32 | Upgrade
|
| Net Income to Common | -5.48 | -0.94 | -9.02 | -1.96 | -27.97 | -18.32 | Upgrade
|
| Shares Outstanding (Basic) | 26 | 26 | 25 | 25 | 21 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 26 | 26 | 25 | 25 | 21 | 18 | Upgrade
|
| Shares Change (YoY) | -0.20% | 1.99% | -0.24% | 19.98% | 18.29% | 176.74% | Upgrade
|
| EPS (Basic) | -0.21 | -0.04 | -0.36 | -0.08 | -1.33 | -1.03 | Upgrade
|
| EPS (Diluted) | -0.21 | -0.04 | -0.36 | -0.08 | -1.33 | -1.03 | Upgrade
|
| Free Cash Flow | 2.11 | 6.82 | 4.78 | -4.73 | -22.4 | -19.12 | Upgrade
|
| Free Cash Flow Per Share | 0.08 | 0.27 | 0.19 | -0.19 | -1.07 | -1.08 | Upgrade
|
| Gross Margin | 59.30% | 66.56% | 67.38% | 87.05% | - | 52.76% | Upgrade
|
| Operating Margin | -15.05% | -3.77% | -38.87% | -6.85% | -69515.38% | -1939.62% | Upgrade
|
| Profit Margin | -15.81% | -2.96% | -42.45% | -8.95% | -71717.95% | -1910.32% | Upgrade
|
| Free Cash Flow Margin | 6.08% | 21.54% | 22.51% | -21.67% | -57425.64% | -1993.95% | Upgrade
|
| EBITDA | -4.17 | -0.36 | -6.55 | -1.12 | -26.59 | -18.28 | Upgrade
|
| EBITDA Margin | -12.03% | -1.13% | -30.81% | -5.13% | - | - | Upgrade
|
| D&A For EBITDA | 1.05 | 0.83 | 1.71 | 0.37 | 0.52 | 0.33 | Upgrade
|
| EBIT | -5.22 | -1.19 | -8.26 | -1.5 | -27.11 | -18.6 | Upgrade
|
| EBIT Margin | -15.05% | -3.77% | -38.87% | -6.85% | - | - | Upgrade
|
| Revenue as Reported | 34.68 | 31.64 | 21.25 | 21.83 | 0.04 | 0.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.